Plasma Human Calcitonin (hCT) Levels in Normal and Pathologic Conditions, and their Responses to Short Calcium or Tetragastrin Infusion
スポンサーリンク
概要
- 論文の詳細を見る
Plasma hCT levels were less than 50pg/ml in 50 normal subjects. In 16 patients with medullary carcinoma of the thyroid (MCT), plasma hCT levels were distinctively elevated and they fell significantly after total thyroidectomy, but in 11 of them plasma levels were still high, indicating the presence of metastases. In 74 patients with the other types of malignancy, plasma hCT levels were found to be high in 9 cases (3 oat cell carcinoma of the lung, 4 malignant carcinoids, one malignant pheochromocytoma and one acute myelocytic leukemia). Except for the leukemic case, all these tumors were derived from neural crest. In 12 patients with primary hyperparathyroidism, plasma hCT levels were less than 20pg/m<I>l</I>. In 13 hypoparathyroid patients, two with pseudohypoparathyroidism and one with pseudoidiopathic hypoparathyroidism, plasma hCT levels were slightly elevated. Some patients with uremia had elevated plasma hCT levels, but there was no relation between plasma levels of hCT and those of PTH, urea nitrogen or creatinine. In response to Ca (4.5mg/kg/10 min) or tetragastrin (4μg/kg/5 min) infusion, a marked increase in plasma hCT was observed in all patients with MCT, but not in normal subjects. In 5 hypoparathyroid patients, a significant increase to both stimuli was also observed in all cases. Two patients with pseudopseudohypoparathyroidism responded to the Ca load.<BR>These results indicate that the determination of plasma hCT levels especially after the short Ca or tetragastrin infusion is important to study various pathological conditions.
- 社団法人 日本内分泌学会の論文
著者
-
YAMAGUCHI KEN
Endocrinology Divisions, National Cancer Center Research Institute
-
Abe Kaoru
Endocrine Division National Cancer Center
-
ADACHI ISAMU
Endocrine Division, National Cancer Center Research Institute
-
TANAKA MASASHIRO
Endocrine Division, National Cancer Center Research Institute
-
MIYAKAWA SUMIKO
Endocrine Division, National Cancer Center Research Institute
-
HIRAKAWA HIDETOSHI
Endocrine Division, National Cancer Center Research Institute
-
TANAKA NOBUYOSHI
Endocrine Division, National Cancer Center Research Institute
-
YAMAGUCHI KEN
Endocrine Division, National Cancer Center Research Institute
関連論文
- Plasma Gastrin Levels and Gastric Acid Secretion in Chronic Renal Failure
- IMMUNOHISTOCHEMICAL AND IMMUNOCYTOCHEMICAL LOCALIZATION OF ATRIAL NATRIURETIC POLYPEPTIDE IN HUMAN ADULT AND FETAL HEARTS
- Cushings Syndrome due to Huge Adrenocortical Multinodular Hyperplasia
- Substance P Radioimmunoassay Using Nα-Tyrosyl-substance P and Demonstration of the Presence of Substance P-like Immunoreactivities in Human Blood and Porcine Tissue Extracts
- Effect of L-Dopa on Anterior Pituitary Hormone Release in Man
- Plasma Human Calcitonin (hCT) Levels in Normal and Pathologic Conditions, and their Responses to Short Calcium or Tetragastrin Infusion
- Phosphaturic Effect of I. V. Administered Calcitonin in Man
- Radioimmunoassay Specific for Amino (N) and Carboxyl (C) Terminal Portion of Parathyroid Hormone
- Radioimmunoassay of Parathyroid Hormone in Human Plasma and Tissue Using Commercially Available Antiserum and Modified Iodination
- Inhibitory effect of calcium channel blockers on .ALPHA.-adrenergic activation of glycogenolysis and calcium efflux in perfused rat liver.